Literature DB >> 29797185

Are Tanycytes the Missing Link Between Type 2 Diabetes and Alzheimer's Disease?

Sudhanshu P Raikwar1,2, Sachin M Bhagavan1, Swathi Beladakere Ramaswamy1, Ramasamy Thangavel1,2, Iuliia Dubova1, Govindhasamy Pushpavathi Selvakumar1,2, Mohammad Ejaz Ahmed1,2, Duraisamy Kempuraj1,2, Smita Zaheer1, Shankar Iyer1,2, Asgar Zaheer3,4.   

Abstract

Tanycytes are highly specialized bipolar ependymal cells that line the ventrolateral wall and the floor of the third ventricle in the brain and form a blood-cerebrospinal fluid barrier at the level of the median eminence. They play a pivotal role in regulating metabolic networks that control body weight and energy homeostasis. Due to the glucosensing function of tanycytes, they could be considered as a critical player in the pathogenesis of type 2 diabetes. Genetic fate mapping studies have established the role of tanycytes for the newly detected adult hypothalamic neurogenesis with important implications for metabolism as well as pathophysiology of various neurodegenerative diseases. We believe that a comprehensive understanding of the physiological mechanisms underlying their neuroplasticity, glucosensing, and cross talk with endothelial cells will enable us to achieve metabolic homeostasis in type 2 diabetes patients and possibly delay the progression of Alzheimer's disease and hopefully improve cognitive function.

Entities:  

Keywords:  Alzheimer’s disease; Glucose homeostasis; Tanycytes; Type 2 diabetes

Mesh:

Year:  2018        PMID: 29797185      PMCID: PMC6344308          DOI: 10.1007/s12035-018-1123-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  63 in total

1.  Multipotent stem cell factor UGS148 is a marker for tanycytes in the adult hypothalamus.

Authors:  Ming-San Ma; Nieske Brouwer; Evelyn Wesseling; Divya Raj; Johannes van der Want; Erik Boddeke; Veerakumar Balasubramaniyan; Sjef Copray
Journal:  Mol Cell Neurosci       Date:  2015-02-07       Impact factor: 4.314

Review 2.  Type 2 diabetes in adolescents and young adults.

Authors:  Nadia Lascar; James Brown; Helen Pattison; Anthony H Barnett; Clifford J Bailey; Srikanth Bellary
Journal:  Lancet Diabetes Endocrinol       Date:  2017-08-25       Impact factor: 32.069

Review 3.  Bidirectional interactions between diabetes and Alzheimer's disease.

Authors:  Mitsuru Shinohara; Naoyuki Sato
Journal:  Neurochem Int       Date:  2017-05-24       Impact factor: 3.921

4.  Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.

Authors:  Dominik Paquet; Dylan Kwart; Antonia Chen; Andrew Sproul; Samson Jacob; Shaun Teo; Kimberly Moore Olsen; Andrew Gregg; Scott Noggle; Marc Tessier-Lavigne
Journal:  Nature       Date:  2016-04-27       Impact factor: 49.962

Review 5.  Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence.

Authors:  Kun-Ming Chan; Sudhanshu P Raikwar; Nicholas Zavazava
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

Authors:  M A Reger; G S Watson; P S Green; C W Wilkinson; L D Baker; B Cholerton; M A Fishel; S R Plymate; J C S Breitner; W DeGroodt; P Mehta; S Craft
Journal:  Neurology       Date:  2007-10-17       Impact factor: 9.910

7.  Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting.

Authors:  Fanny Langlet; Barry E Levin; Serge Luquet; Massimiliano Mazzone; Andrea Messina; Ambrose A Dunn-Meynell; Eglantine Balland; Amelie Lacombe; Daniele Mazur; Peter Carmeliet; Sebastien G Bouret; Vincent Prevot; Bénédicte Dehouck
Journal:  Cell Metab       Date:  2013-04-02       Impact factor: 27.287

8.  FGF19 action in the brain induces insulin-independent glucose lowering.

Authors:  Gregory J Morton; Miles E Matsen; Deanna P Bracy; Thomas H Meek; Hong T Nguyen; Darko Stefanovski; Richard N Bergman; David H Wasserman; Michael W Schwartz
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

9.  Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism.

Authors:  Geneviève Marcelin; Young-Hwan Jo; Xiaosong Li; Gary J Schwartz; Ying Zhang; Nae J Dun; Rong-Ming Lyu; Clémence Blouet; Jaw K Chang; Streamson Chua
Journal:  Mol Metab       Date:  2013-10-23       Impact factor: 7.422

10.  Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.

Authors:  I Moreno-Gonzalez; G Edwards Iii; N Salvadores; M Shahnawaz; R Diaz-Espinoza; C Soto
Journal:  Mol Psychiatry       Date:  2017-01-03       Impact factor: 15.992

View more
  3 in total

Review 1.  Consequences of Metabolic Disruption in Alzheimer's Disease Pathology.

Authors:  J C Ryu; E R Zimmer; P Rosa-Neto; S O Yoon
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 2.  Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?

Authors:  Sudhanshu P Raikwar; Ramasamy Thangavel; Iuliia Dubova; Mohammad Ejaz Ahmed; Pushpavathi Govindhasamy Selvakumar; Duraisamy Kempuraj; Smita Zaheer; Shankar Iyer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  ACSA-2 and GLAST classify subpopulations of multipotent and glial-restricted cerebellar precursors.

Authors:  Christina Geraldine Kantzer; Elena Parmigiani; Valentina Cerrato; Stefan Tomiuk; Michail Knauel; Melanie Jungblut; Annalisa Buffo; Andreas Bosio
Journal:  J Neurosci Res       Date:  2021-05-31       Impact factor: 4.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.